Cargando…

575. Evaluation of Risk Factors and Clinical Outcomes of Patients with Vancomycin-Resistant Enterococcus Infections

BACKGROUND: Vancomycin-resistant Enterococci (VRE) occurs with enhanced frequency in hospitalized patients and are usually associated with poor clinical outcomes. The purpose of this study was to evaluate the risk factors and clinical outcomes of patients with VRE infections. METHODS: This study was...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chauhan, Gauri, Vyas, Nikunj M, Levin, Todd P, Kim, Sungwook
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810598/ http://dx.doi.org/10.1093/ofid/ofz360.644

Ejemplares similares

2402. Evaluating Clinical Outcomes of Adjunctive Beta-Lactam Use in Vancomycin-Resistant Enterococcus Infective Endocarditis
por: Khan, Ebrahim H, et al.
Publicado: (2023)

523. Dual vs. Triple Antibiotic Therapy for Carbapenem-Resistant Acinetobacter baumannii Infections
por: Markelwith, Justin Patrick, et al.
Publicado: (2019)

2441. Outcomes of Patients With Vancomycin-Resistant Enterococcus Blood Stream Infections (BSI) Treated With Daptomycin
por: Shimose, Luis A, et al.
Publicado: (2018)

Predictors of Vancomycin-Resistant Enterococcus (VRE) Bacteremia in Ontario, Canada
por: Johnstone, Jennie, et al.
Publicado: (2017)

Risk factors for non-vancomycin-resistant enterococcus faecium infection
por: Jiménez, R, et al.
Publicado: (2015)

733 Vancomycin-Resistant Enterococcus (VRE) faecium Bloodstream Infections and Mortality
por: Suleyman, Geehan, et al.
Publicado: (2014)

P23 Rates, treatment and outcomes of vancomycin-resistant Enterococcus faecium bacteraemia at Addenbrooke’s Hospital
por: Barnes, David, et al.
Publicado: (2023)

Epidemiology, Associated Conditions, and Outcomes of Hospital Associated Vancomycin-Resistant Enterococcus Infections in the US Military Health Care System
por: Stagliano, David, et al.
Publicado: (2017)

2444. Incidence of Daptomycin Toxicity Among Patients With Vancomycin-Resistant Enterococcus Blood Stream Infections
por: Rios, Maria X Bueno, et al.
Publicado: (2018)

Comparative Effectiveness of Vancomycin vs. Metronidazole in Mild Clostridium difficile Infections, and Potential Impact on Subsequent Vancomycin-Resistant Enterococcus (VRE) Isolation
por: Youngster, Ilan, et al.
Publicado: (2017)

2413. Assessment of compliance with Clostridioides difficile prophylaxis guideline and its efficacy on secondary prophylaxis and reducing hospital-onset Clostridioides difficile infections.
por: Vyas, Nikunj M, et al.
Publicado: (2019)

649. The Clinical Significance of Sequence Type 17 of Vancomycin-Resistant Enterococcus faecium
por: Kim, Si-Ho, et al.
Publicado: (2018)

1772. Vancomycin-Resistant Enterococcus Alters the Gastrointestinal Microbiome in Critically Ill Patients
por: Cuaresma, Edward, et al.
Publicado: (2018)

1990. A Strategy of Mandatory Infectious Disease Consultations on Hospital-acquired Clostridium difficile Infection and Antimicrobial Utilization
por: Hou, Cindy, et al.
Publicado: (2019)

1527. Clinical Variables Associated with Vancomycin Resistance in Children with Bacteremia Due to Enterococcus spp.
por: Jimena, Carla, et al.
Publicado: (2019)

Gut colonization with vancomycin-resistant Enterococcus and risk for subsequent enteric infection
por: Axelrad, Jordan E., et al.
Publicado: (2018)

1611. Evaluating Clinical Outcomes and Efficacy of Daptomycin in Combination with a Beta-Lactam for the Treatment of Vancomycin-Resistant Enterococcus (VRE) Bacteremia
por: Irusta, Nerea, et al.
Publicado: (2020)

Risk Factors and Outcomes of Vancomycin-Resistant vs. Vancomycin-Sensitive Enterococcal Blood Stream Infections in Patients with Acute Myeloid Leukemia
por: Addisu, Anteneh, et al.
Publicado: (2017)

575. Older HIV-Infected Adults Are Twice More Likely to Present Late to Care
por: Rizk, Christina, et al.
Publicado: (2018)

Trends of Vancomycin-Resistant Enterococcus Infections in Cancer Patients
por: Rafey, Abdur, et al.
Publicado: (2022)

853. Hospital-acquired Infections by Vancomycin-Resistant Enterococcus (VRE): Results in 3 Years of Multicenter Study
por: Tanure, Luciana Coelho, et al.
Publicado: (2020)

576. A Multicenter Epidemiology Study on Risk Factors of Vancomycin-Resistant Enterococcus Infections in China: Results from the China Antimicrobial Surveillance Network (CHINET) in 2016
por: Lin, Dongfang, et al.
Publicado: (2019)

1255. First Outbreak Due to Vancomycin-Resistant Enterococcus Epidemic Clone ST796 in Europe
por: Wassilew, Nasstasja, et al.
Publicado: (2018)

Adherence to Institutional Guidelines for Community and Nosocomial Pneumonia and Its Impact on In-hospital Mortality and 30-day Readmission in a Community Health System
por: Lanza, David, et al.
Publicado: (2017)

Risk Factors and Outcomes Associated With Acquisition of Daptomycin and Linezolid–Nonsusceptible Vancomycin-Resistant Enterococcus
por: Greene, Matthew H, et al.
Publicado: (2018)

Vancomycin-resistant Enterococcus faecalis in Serbia
por: Stošović, Branka, et al.
Publicado: (2004)

Genomics of vancomycin-resistant Enterococcus faecium
por: Gorrie, Claire, et al.
Publicado: (2019)

Vancomycin Resistance in Enterococcus and Staphylococcus aureus
por: Li, Gen, et al.
Publicado: (2022)

735. Bacteriophage Therapy Improves Survival of Galleria mellonella Larvae Injected with Vancomycin-Resistant Enterococcus faecium
por: El Haddad, Lynn, et al.
Publicado: (2019)

Presence of virulence factors in Enterococcus faecalis and Enterococcus faecium susceptible and resistant to vancomycin
por: Comerlato, Carolina Baldisserotto, et al.
Publicado: (2013)

Virulence factors in vancomycin-resistant and vancomycin- susceptible Enterococcus faecalis from Brazil
por: Camargo, I. L. B. C., et al.
Publicado: (2008)

202. Implementation and Three-Year Results of Antimicrobial Stewardship Program in a Three Hospital Community Health System
por: Vyas, Nikunj, et al.
Publicado: (2018)

634. Incidence of vanC-Mediated Vancomycin-Resistant Enterococcus Bloodstream Infections at Children’s Hospital of Colorado and Implications for Empiric Enterococcal Therapy
por: Dodson, Daniel S, et al.
Publicado: (2019)

137. Penicillin (PCN) Gradient Diffusion Overcalls Resistance and Promotes Unnecessary Vancomycin (VAN) Use in Enterococcus faecalis Bloodstream Infections (BSI)
por: Donohue, Lindsay E, et al.
Publicado: (2023)

Gut Microbiota Predict Enterococcus Expansion but Not Vancomycin-Resistant Enterococcus Acquisition
por: Chanderraj, Rishi, et al.
Publicado: (2020)

280. The Impact of a Revised Neutropenic Fever Guideline on Vancomycin-Resistant Enterococcus Rates in Pediatric Oncology Patients
por: Karandikar, Manjiree, et al.
Publicado: (2018)

574. Reporting of Vancomycin-Resistant Enterococcus Bacteremia among National Healthcare Safety Network Acute Care Hospitals
por: Tanwar, Sukarma S S, et al.
Publicado: (2019)

Spatiotemporal prediction of vancomycin-resistant Enterococcus colonisation
por: van Niekerk, J. M., et al.
Publicado: (2022)

The Evaluation of Risk Factors for Vancomycin-Resistant Enterococcus Colonization and Infection Among Mixed Adult Intensive Care Unit Patients
por: Doganci, Melek, et al.
Publicado: (2023)

735. Vancomycin-Resistant vanB- and vanA/vanB-type Enterococcus faecium Causing Invasive Infections in Adult Patients in Chile
por: Diaz, Lorena, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_nbsfpbbe80mqhdn1qc2j3kh75e